Product Launch (Blog)

Europe Medical Device Reprocessing Market is expected to grow exponentially from the past year due to increasing healthcare cost containment measures, heightened environmental sustainability efforts, and the rising adoption of reprocessed devices for their cost-effectiveness and comparable performance to new devices.

Figure 1: Medical Device Reprocessing

Source- DBMR Analysis

By Definition

Medical device reprocessing is a systematic practice that involves the collection, cleaning, disinfection, sterilization, and rigorous testing of used medical devices to ensure they meet the required safety and performance standards for reuse. This process starts with collecting and sorting devices based on their type and condition, followed by meticulous cleaning to remove all contaminants. The devices are then disinfected and sterilized to eliminate any microbial life, ensuring they are safe for reuse.

Rigorous testing and quality control measures are employed to verify the efficacy of the reprocessing procedures, after which the devices are appropriately packaged and labeled for redistribution. This practice offers significant benefits, including cost savings for healthcare facilities, reduced medical waste contributing to environmental sustainability, and optimization of healthcare resources by extending the lifecycle of medical devices. Reprocessed devices must comply with stringent regulatory standards, ensuring they are safe and effective for patient care.

Medical device reprocessing in Europe has evolved significantly from its early informal practices in the early 20th century, where basic sterilization methods were used to manage economic constraints and limited availability of new devices. The mid-20th century saw a decline in reprocessing with the rise of single-use devices, but economic pressures maintained its presence. In the 1980s, heightened awareness of hospital-acquired infections spurred more standardized practices, and by the 1990s, the European Union began regulating reprocessing through the Medical Devices Directive. Germany emerged as a leader in developing stringent standards, influencing practices across Europe. The 2000s brought increased adoption driven by cost savings and environmental benefits, and the introduction of the Medical Device Regulation in 2017 ensured reprocessed devices met rigorous safety and performance criteria. Today, technological advancements and a strong focus on sustainability drive reprocessing practices in Europe, aligning with broader EU environmental goals and making reprocessing a critical aspect of modern healthcare systems.

Figure 2: Reusable Medical Devices, Reprocessing, and Design for Maintenance

Source- DBMR Analysis

Configuration Services

In medical device reprocessing, a comprehensive set of procedures and standards is employed to ensure the safety, efficacy, and regulatory compliance of reprocessed devices. These procedures include rigorous cleaning, disinfection, and sterilization processes, often using advanced techniques like autoclaving or ethylene oxide sterilization. Visual and functional inspections are conducted to detect any damage or defects, and validation processes verify that sterilization parameters are consistently met. Compliance with EU regulations, particularly the Medical Device Regulation (MDR), is paramount, requiring proper labeling, documentation, and adherence to national guidelines. Quality assurance measures, including robust quality management systems and traceability practices, are implemented to maintain high standards. Environmental sustainability is also a consideration, with efforts made to minimize waste and use eco-friendly practices. These practices ensure that reprocessed devices meet strict safety and quality standards, supporting patient safety and sustainable healthcare practices.

Market Developments

  • In April 2021, Stryker announced their multiyear national partnership, designating the medical device company as the Official Smart Robotics Joint Replacement Partner of Minor League Baseball. This partnership gives a solid foundation for growth and reputation
  • In January 2021, Johnson & Johnson Services, Inc. announced that DePuy Synthes received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VELYS Robotic-Assisted Solution designed ATTUNE Total Knee System and its cleared indications for use. It will increase their sales in the present and future with growing demand in the market
  • The increased use of reusable cardiac catheters in Europe is present due to the rise in the number of cardiac surgeries in Europe, which increased by 101% to 413,520 operations (797 per 10(6) population
  • In November 2020, Stryker announced the acquisition of Wright Medical Group N.V. (NASDAQ: WMGI), a global medical device company focused on extremities and biologics. This acquisition will enhance their global market position in trauma and extremities, providing significant opportunities to advance innovation and reach more patients
  • In May 2020, Medline Industries Inc. had partnered with Innovative Health to introduce the industry's renewal and reprocessing program and services. The partnership would result in gaining the advantage of the reprocessing products and services and maximization of savings
  • In April 2020, the Belgian Federal Agency of Medicines and Health Products had released an official work statement circular that stated establishing the conditions and the means with which health care organizations may respond to emergency shortages of essential materials either through manufacturing medical devices or by reprocessing of medical devices. It also states that certain medical devices labeled as single-use may be used again

Future Opportunities -

Furthermore, increased awareness among healthcare professionals and patients regarding the benefits of orthotic devices in managing neuromuscular disorders is driving market demand. Orthotists and clinicians are actively involved in prescribing and customizing orthotic solutions based on individual needs and specific neuromuscular conditions. Patients with NMDs are increasingly seeking these devices to improve their mobility, maintain independence, and enhance their overall quality of life.

A global aging population also influences the market for neuromuscular disorders. The demand for orthotic solutions to aid this demographic is anticipated to rise as the prevalence of neuromuscular disorders tends to increase with age. In addition, ongoing research and development efforts aimed at creating more advanced and effective orthotic devices for neuromuscular disorders are expected to further boost the market growth, meeting the evolving needs of individuals living with these conditions.

Technological Advancements in Orthotics

Advancements in technology are transforming medical device reprocessing, making it safer, more efficient, and environmentally friendly. One key area of advancement is in sterilization methods. Traditional methods such as autoclaving and ethylene oxide sterilization are being complemented by newer technologies such as hydrogen peroxide gas plasma sterilization and ozone sterilization. These methods offer faster cycle times, reduced environmental impact, and compatibility with a wider range of materials.

Automation is another significant trend. Automated reprocessing systems streamline the process, reducing the risk of human error and ensuring consistent, high-quality outcomes. These systems often include features like robotic loading and unloading, advanced monitoring and control systems, and integration with hospital information systems for seamless tracking and documentation.

Technological innovations also extend to quality control and assurance.

For instance,

  • Advanced imaging technologies can be used for more accurate inspection of devices, detecting even microscopic defects that could compromise safety. In addition, RFID and other tracking technologies are being utilized for better traceability, ensuring that reprocessed devices can be easily traced back to their original source and reprocessing history

Overall, these technological advancements are driving the future of medical device reprocessing in Europe, making it a more reliable, efficient, and sustainable practice.

Related Reports-


Client Testimonials